Daily Injection of Anakinra Effective in Active Ankylosing Spondylitis

"Daily treatment with anakinra is effective in controlling the clinical manifestations of ankylosing spondylitis (AS), with a 61% improvement in spinal and sacroiliac joint (SIJ) enthesitis/osteitis, according to results of a three-month, open-label, proof-of-concept pilot study published in the September issue of the Annals of the Rheumatic Diseases."